Immunocore Holdings plc - ADR

NASDAQ:IMCR  
28.67
-3.48 (-10.81%)
Earnings Announcements

Immunocore Reports Third Quarter 2021 Financial Results

Published: 11/10/2021 12:29 GMT
Immunocore Holdings plc - ADR (IMCR) - Immunocore Reports Third Quarter 2021 Financial Results and Provides Business Update.
Q3 Loss per Share GBP 0.69.
Immunocore Holdings - Qtrly Revenue GBP 5.9 Million Versus GBP 6.7 Million.
Q3 Earnings per Share View $-1.05, Revenue View $7.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $8.35 Million
Adjusted EPS is expected to be -$1.06

Next Quarter Revenue Guidance is expected to be $6.89 Million
Next Quarter EPS Guidance is expected to be -$1.06

More details on our Analysts Page.